Golden State Equity Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-260
Closed -$30K 709
2024
Q3
$30K Buy
+260
New +$30K 0.02% 462